Bortezomib: Understanding the mechanism of action

Bilal Piperdi, Yi He Ling, Leonard Liebes, Franco Muggia, Roman Perez-Soler

Research output: Contribution to journalArticle

32 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2029-2030
Number of pages2
JournalMolecular Cancer Therapeutics
Volume10
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Proto-Oncogene Proteins c-bcl-2
Tosylphenylalanyl Chloromethyl Ketone
Multienzyme Complexes
Boronic Acids
Pyrazines
Protease Inhibitors
Antineoplastic Agents
Apoptosis
Bortezomib

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bortezomib : Understanding the mechanism of action. / Piperdi, Bilal; Ling, Yi He; Liebes, Leonard; Muggia, Franco; Perez-Soler, Roman.

In: Molecular Cancer Therapeutics, Vol. 10, No. 11, 11.2011, p. 2029-2030.

Research output: Contribution to journalArticle

Piperdi, Bilal ; Ling, Yi He ; Liebes, Leonard ; Muggia, Franco ; Perez-Soler, Roman. / Bortezomib : Understanding the mechanism of action. In: Molecular Cancer Therapeutics. 2011 ; Vol. 10, No. 11. pp. 2029-2030.
@article{b725d77be6a24fa9a7cffca20177b2a8,
title = "Bortezomib: Understanding the mechanism of action",
author = "Bilal Piperdi and Ling, {Yi He} and Leonard Liebes and Franco Muggia and Roman Perez-Soler",
year = "2011",
month = "11",
doi = "10.1158/1535-7163.MCT-11-0745",
language = "English (US)",
volume = "10",
pages = "2029--2030",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Bortezomib

T2 - Understanding the mechanism of action

AU - Piperdi, Bilal

AU - Ling, Yi He

AU - Liebes, Leonard

AU - Muggia, Franco

AU - Perez-Soler, Roman

PY - 2011/11

Y1 - 2011/11

UR - http://www.scopus.com/inward/record.url?scp=81055124278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81055124278&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-11-0745

DO - 10.1158/1535-7163.MCT-11-0745

M3 - Article

C2 - 22072812

AN - SCOPUS:81055124278

VL - 10

SP - 2029

EP - 2030

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 11

ER -